Apitope has posted phase 2a data on the multiple sclerosis drug Merck KGaA walked away from last year.

IBM Watson was set to announce new partnerships on Monday, but reports of the company’s partnership with MD Anderson being put on hold may have stolen its…

VBL Therapeutics has presented more data from a phase 2 trial of VB-111 monotherapy in thyroid cancer patients.

Cidara Therapeutics will stop work on its antifungal CD101 in women with acute VVC, after the topical candidate failed a mid-stage trial.

Sarepta has struck a $125 million deal to sell a voucher it got with last year’s controversial FDA approval of its new Duchenne drug to Gilead, which will give…

Nordic Nanovector CEO Luigi Costa has talked up the level of third-party interest in non-Hodgkin lymphoma candidate Betalutin.

Scientists at Emory University’s Winship Cancer Institute are on a mission to unlock the mysteries of lung cancer cells that have long been thought to be…

Scientists led by the University of Washington are reporting success using gene therapy to treat dogs with a rare disorder called myotubular myopathy (MTM).…

Biotronik has received FDA approval for a bare-metal stent designed to treat coronary artery disease.